Small Animal Imaging (In-Vivo) Market Size, Share and Growth Outlook 2026: By Modality, By Component, By Application, By End-User, Companies to 2034
The global Small Animal Imaging (In-Vivo) Market size is forecast to increase from $1.5 Billion in 2026 to $2.68 Billion in 2034 at a CAGR of 7.5% between 2026 and 2034.
The Small Animal Imaging (In-Vivo) market report provides detailed analysis and outlook of Small Animal Imaging (In-Vivo) segments including By Modality (Optical Imaging Systems, Micro-Computed Tomography, Micro-Magnetic Resonance Imaging, Nuclear Imaging Systems, Micro-Ultrasound Imaging, Photoacoustic Imaging Systems, Magnetic Particle Imaging (MPI) Systems), By Component (Devices / Instruments, Reagents and Contrast Agents, Software and Analytics), By Application (Oncology, Cardiology, Neurology and Central Nervous System (CNS) Diseases, Infectious and Immunological Diseases, Biodistribution and Pharmacokinetics Studies), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Small Animal Imaging (In-Vivo) Industry Overview
Multimodal imaging, quantitative analysis, and real-time biological monitoring are transforming preclinical research.
The global small animal imaging (in-vivo) industry is advancing through the adoption of multimodal imaging systems, standardized imaging biomarkers, and automated analytical software that improve the quality and translational value of preclinical research. Increasing demand for more accurate disease modeling, longitudinal therapeutic evaluation, and quantitative biological assessment is encouraging research organizations to integrate multiple imaging modalities within unified workflows. Technology providers are also enhancing software capabilities that enable researchers to capture dynamic biological processes rather than relying solely on static imaging observations, supporting more predictive drug development and precision medicine research.
Integrated multimodal platforms are improving translational research capabilities.
The industry is increasingly adopting comprehensive imaging ecosystems that generate complementary biological information from individual research subjects. Bruker Corporation continues emphasizing multimodal preclinical imaging by integrating MRI, PET, SPECT/CT, and optical imaging technologies into unified research platforms. This strategy enables investigators to collect diverse biological datasets from the same animal, improving statistical power while supporting more comprehensive longitudinal studies across oncology and neuroscience research. Complementing these efforts, the Frederick National Laboratory (FNL) for Cancer Research continues advancing standardized imaging biomarkers through its Small Animal Imaging Program, utilizing integrated PET/CT, MRI, and high-frequency ultrasound to characterize primary and metastatic tumor models while establishing reproducible imaging benchmarks that strengthen translational oncology research and therapeutic evaluation.
Real-time imaging analytics are enhancing pharmacokinetic and therapeutic response studies.
A growing industry focus is the transition from single-timepoint imaging toward dynamic analysis of biological activity throughout experimental studies. Modern imaging platforms increasingly incorporate advanced Kinetics modes capable of continuously tracking the rise, plateau, and decay of bioluminescent and fluorescent signals in real time. These automated analytical capabilities provide more accurate quantification of target expression, pharmacokinetics, and therapeutic response while enabling researchers to evaluate complex biological processes with greater precision. Continued innovation in multimodal imaging systems, standardized biomarker development, and real-time quantitative analytics is strengthening the role of in-vivo small animal imaging in accelerating drug discovery, oncology research, and translational biomedical science.
Small Animal Imaging (In-Vivo) Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Small Animal Imaging (In-Vivo) market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Bruker Corporation, PerkinElmer Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation (VisualSonics), Mediso Ltd., LI-COR Biosciences, MR Solutions Ltd., MILabs B.V. (Rigaku Corporation), Aspect Imaging Ltd., TriFoil Imaging Inc.. The Small Animal Imaging (In-Vivo) market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Small Animal Imaging (In-Vivo) industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Small Animal Imaging (In-Vivo) industry include- Bruker Corporation, PerkinElmer Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation (VisualSonics), Mediso Ltd., LI-COR Biosciences, MR Solutions Ltd., MILabs B.V. (Rigaku Corporation), Aspect Imaging Ltd., TriFoil Imaging Inc.. The Small Animal Imaging (In-Vivo) market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Small Animal Imaging (In-Vivo) Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Small Animal Imaging (In-Vivo) market remains one of the strongest-performing segments in the country.
The US Small Animal Imaging (In-Vivo) Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Small Animal Imaging (In-Vivo) market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Small Animal Imaging (In-Vivo) industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Small Animal Imaging (In-Vivo) markets
Canada's strong Small Animal Imaging (In-Vivo) sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Small Animal Imaging (In-Vivo) market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Small Animal Imaging (In-Vivo) Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Small Animal Imaging (In-Vivo) market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Small Animal Imaging (In-Vivo) population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Small Animal Imaging (In-Vivo) industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Small Animal Imaging (In-Vivo) market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Small Animal Imaging (In-Vivo) sales through 2034
France Small Animal Imaging (In-Vivo) companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Small Animal Imaging (In-Vivo) Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Small Animal Imaging (In-Vivo) distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Small Animal Imaging (In-Vivo) Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Small Animal Imaging (In-Vivo) market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Small Animal Imaging (In-Vivo) industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Small Animal Imaging (In-Vivo) industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Small Animal Imaging (In-Vivo) Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Small Animal Imaging (In-Vivo) market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Small Animal Imaging (In-Vivo) market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Small Animal Imaging (In-Vivo) Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Small Animal Imaging (In-Vivo) Market Segmentation
By Modality
Optical Imaging Systems
Micro-Computed Tomography
Micro-Magnetic Resonance Imaging
Nuclear Imaging Systems
Micro-Ultrasound Imaging
Photoacoustic Imaging Systems
Magnetic Particle Imaging (MPI) Systems
By Component
Devices / Instruments
Reagents and Contrast Agents
Software and Analytics
By Application
Oncology
Cardiology
Neurology and Central Nervous System (CNS) Diseases
Infectious and Immunological Diseases
Biodistribution and Pharmacokinetics Studies
By End-User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
Leading Companies in Small Animal Imaging (In-Vivo) Industry (2026)
Bruker Corporation
PerkinElmer Inc.
Siemens Healthineers AG
FUJIFILM Holdings Corporation (VisualSonics)
Mediso Ltd.
LI-COR Biosciences
MR Solutions Ltd.
MILabs B.V. (Rigaku Corporation)
Aspect Imaging Ltd.
TriFoil Imaging Inc.
Countries Included
The Small Animal Imaging (In-Vivo) market report provides detailed analysis and outlook of Small Animal Imaging (In-Vivo) segments including By Modality (Optical Imaging Systems, Micro-Computed Tomography, Micro-Magnetic Resonance Imaging, Nuclear Imaging Systems, Micro-Ultrasound Imaging, Photoacoustic Imaging Systems, Magnetic Particle Imaging (MPI) Systems), By Component (Devices / Instruments, Reagents and Contrast Agents, Software and Analytics), By Application (Oncology, Cardiology, Neurology and Central Nervous System (CNS) Diseases, Infectious and Immunological Diseases, Biodistribution and Pharmacokinetics Studies), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Small Animal Imaging (In-Vivo) Industry Overview
Multimodal imaging, quantitative analysis, and real-time biological monitoring are transforming preclinical research.
The global small animal imaging (in-vivo) industry is advancing through the adoption of multimodal imaging systems, standardized imaging biomarkers, and automated analytical software that improve the quality and translational value of preclinical research. Increasing demand for more accurate disease modeling, longitudinal therapeutic evaluation, and quantitative biological assessment is encouraging research organizations to integrate multiple imaging modalities within unified workflows. Technology providers are also enhancing software capabilities that enable researchers to capture dynamic biological processes rather than relying solely on static imaging observations, supporting more predictive drug development and precision medicine research.
Integrated multimodal platforms are improving translational research capabilities.
The industry is increasingly adopting comprehensive imaging ecosystems that generate complementary biological information from individual research subjects. Bruker Corporation continues emphasizing multimodal preclinical imaging by integrating MRI, PET, SPECT/CT, and optical imaging technologies into unified research platforms. This strategy enables investigators to collect diverse biological datasets from the same animal, improving statistical power while supporting more comprehensive longitudinal studies across oncology and neuroscience research. Complementing these efforts, the Frederick National Laboratory (FNL) for Cancer Research continues advancing standardized imaging biomarkers through its Small Animal Imaging Program, utilizing integrated PET/CT, MRI, and high-frequency ultrasound to characterize primary and metastatic tumor models while establishing reproducible imaging benchmarks that strengthen translational oncology research and therapeutic evaluation.
Real-time imaging analytics are enhancing pharmacokinetic and therapeutic response studies.
A growing industry focus is the transition from single-timepoint imaging toward dynamic analysis of biological activity throughout experimental studies. Modern imaging platforms increasingly incorporate advanced Kinetics modes capable of continuously tracking the rise, plateau, and decay of bioluminescent and fluorescent signals in real time. These automated analytical capabilities provide more accurate quantification of target expression, pharmacokinetics, and therapeutic response while enabling researchers to evaluate complex biological processes with greater precision. Continued innovation in multimodal imaging systems, standardized biomarker development, and real-time quantitative analytics is strengthening the role of in-vivo small animal imaging in accelerating drug discovery, oncology research, and translational biomedical science.
Small Animal Imaging (In-Vivo) Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Small Animal Imaging (In-Vivo) market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Bruker Corporation, PerkinElmer Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation (VisualSonics), Mediso Ltd., LI-COR Biosciences, MR Solutions Ltd., MILabs B.V. (Rigaku Corporation), Aspect Imaging Ltd., TriFoil Imaging Inc.. The Small Animal Imaging (In-Vivo) market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Small Animal Imaging (In-Vivo) industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Small Animal Imaging (In-Vivo) Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Small Animal Imaging (In-Vivo) companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Small Animal Imaging (In-Vivo) markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Small Animal Imaging (In-Vivo) industry include- Bruker Corporation, PerkinElmer Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation (VisualSonics), Mediso Ltd., LI-COR Biosciences, MR Solutions Ltd., MILabs B.V. (Rigaku Corporation), Aspect Imaging Ltd., TriFoil Imaging Inc.. The Small Animal Imaging (In-Vivo) market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Small Animal Imaging (In-Vivo) Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Small Animal Imaging (In-Vivo) market remains one of the strongest-performing segments in the country.
The US Small Animal Imaging (In-Vivo) Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Small Animal Imaging (In-Vivo) market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Small Animal Imaging (In-Vivo) industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Small Animal Imaging (In-Vivo) markets
Canada's strong Small Animal Imaging (In-Vivo) sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Small Animal Imaging (In-Vivo) market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Small Animal Imaging (In-Vivo) Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Small Animal Imaging (In-Vivo) market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Small Animal Imaging (In-Vivo) population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Small Animal Imaging (In-Vivo) industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Small Animal Imaging (In-Vivo) market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Small Animal Imaging (In-Vivo) sales through 2034
France Small Animal Imaging (In-Vivo) companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Small Animal Imaging (In-Vivo) Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Small Animal Imaging (In-Vivo) distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Small Animal Imaging (In-Vivo) Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Small Animal Imaging (In-Vivo) market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Small Animal Imaging (In-Vivo) industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Small Animal Imaging (In-Vivo) industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Small Animal Imaging (In-Vivo) Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Small Animal Imaging (In-Vivo) market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Small Animal Imaging (In-Vivo) market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Small Animal Imaging (In-Vivo) Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Small Animal Imaging (In-Vivo) Market Segmentation
By Modality
Optical Imaging Systems
Micro-Computed Tomography
Micro-Magnetic Resonance Imaging
Nuclear Imaging Systems
Micro-Ultrasound Imaging
Photoacoustic Imaging Systems
Magnetic Particle Imaging (MPI) Systems
By Component
Devices / Instruments
Reagents and Contrast Agents
Software and Analytics
By Application
Oncology
Cardiology
Neurology and Central Nervous System (CNS) Diseases
Infectious and Immunological Diseases
Biodistribution and Pharmacokinetics Studies
By End-User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
Leading Companies in Small Animal Imaging (In-Vivo) Industry (2026)
Bruker Corporation
PerkinElmer Inc.
Siemens Healthineers AG
FUJIFILM Holdings Corporation (VisualSonics)
Mediso Ltd.
LI-COR Biosciences
MR Solutions Ltd.
MILabs B.V. (Rigaku Corporation)
Aspect Imaging Ltd.
TriFoil Imaging Inc.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Small Animal Imaging (In-Vivo) Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Small Animal Imaging (In-Vivo) Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SMALL ANIMAL IMAGING (IN-VIVO) MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Small Animal Imaging (In-Vivo) Markets in 2026
3.2. Global Historic and Forecast Small Animal Imaging (In-Vivo) Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Small Animal Imaging (In-Vivo) Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Small Animal Imaging (In-Vivo) Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Small Animal Imaging (In-Vivo) Value Chain
CHAPTER 4- SMALL ANIMAL IMAGING (IN-VIVO) MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Small Animal Imaging (In-Vivo) Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SMALL ANIMAL IMAGING (IN-VIVO) MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Modality
Optical Imaging Systems
Micro-Computed Tomography
Micro-Magnetic Resonance Imaging
Nuclear Imaging Systems
Micro-Ultrasound Imaging
Photoacoustic Imaging Systems
Magnetic Particle Imaging (MPI) Systems
By Component
Devices / Instruments
Reagents and Contrast Agents
Software and Analytics
By Application
Oncology
Cardiology
Neurology and Central Nervous System (CNS) Diseases
Infectious and Immunological Diseases
Biodistribution and Pharmacokinetics Studies
By End-User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Small Animal Imaging (In-Vivo) Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
7.5. North America Small Animal Imaging (In-Vivo) Market Size Outlook by Type
7.6. North America Small Animal Imaging (In-Vivo) Market Size Outlook by Application
7.7. North America Small Animal Imaging (In-Vivo) Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Small Animal Imaging (In-Vivo) Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Small Animal Imaging (In-Vivo) Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Small Animal Imaging (In-Vivo) Companies
CHAPTER 8- EUROPE SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Small Animal Imaging (In-Vivo) Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
8.5. Europe Small Animal Imaging (In-Vivo) Market Size Outlook by Type
8.6. Europe Small Animal Imaging (In-Vivo) Market Size Outlook by Application
8.7. Europe Small Animal Imaging (In-Vivo) Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Small Animal Imaging (In-Vivo) Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Small Animal Imaging (In-Vivo) Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Small Animal Imaging (In-Vivo) Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Small Animal Imaging (In-Vivo) Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Small Animal Imaging (In-Vivo) Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Small Animal Imaging (In-Vivo) Companies
CHAPTER 9- ASIA PACIFIC SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Small Animal Imaging (In-Vivo) Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Small Animal Imaging (In-Vivo) Market Size Outlook by Type
9.6. Asia Pacific Small Animal Imaging (In-Vivo) Market Size Outlook by Application
9.7. Asia Pacific Small Animal Imaging (In-Vivo) Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Small Animal Imaging (In-Vivo) Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Small Animal Imaging (In-Vivo) Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Small Animal Imaging (In-Vivo) Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Small Animal Imaging (In-Vivo) Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Small Animal Imaging (In-Vivo) Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Small Animal Imaging (In-Vivo) Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Small Animal Imaging (In-Vivo) Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
10.5. South and Central America Small Animal Imaging (In-Vivo) Market Size Outlook by Type
10.6. South and Central America Small Animal Imaging (In-Vivo) Market Size Outlook by Application
10.7. South and Central America Small Animal Imaging (In-Vivo) Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Small Animal Imaging (In-Vivo) Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Small Animal Imaging (In-Vivo) Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Small Animal Imaging (In-Vivo) Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Small Animal Imaging (In-Vivo) Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Small Animal Imaging (In-Vivo) Market Size Outlook by Type
11.6. Middle East and Africa Small Animal Imaging (In-Vivo) Market Size Outlook by Application
11.7. Middle East and Africa Small Animal Imaging (In-Vivo) Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Small Animal Imaging (In-Vivo) Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Small Animal Imaging (In-Vivo) Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Small Animal Imaging (In-Vivo) Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Small Animal Imaging (In-Vivo) Industry
Bruker Corporation
PerkinElmer Inc.
Siemens Healthineers AG
FUJIFILM Holdings Corporation (VisualSonics)
Mediso Ltd.
LI-COR Biosciences
MR Solutions Ltd.
MILabs B.V. (Rigaku Corporation)
Aspect Imaging Ltd.
TriFoil Imaging Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Small Animal Imaging (In-Vivo) Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Small Animal Imaging (In-Vivo) Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SMALL ANIMAL IMAGING (IN-VIVO) MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Small Animal Imaging (In-Vivo) Markets in 2026
3.2. Global Historic and Forecast Small Animal Imaging (In-Vivo) Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Small Animal Imaging (In-Vivo) Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Small Animal Imaging (In-Vivo) Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Small Animal Imaging (In-Vivo) Value Chain
CHAPTER 4- SMALL ANIMAL IMAGING (IN-VIVO) MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Small Animal Imaging (In-Vivo) Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SMALL ANIMAL IMAGING (IN-VIVO) MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Modality
Optical Imaging Systems
Micro-Computed Tomography
Micro-Magnetic Resonance Imaging
Nuclear Imaging Systems
Micro-Ultrasound Imaging
Photoacoustic Imaging Systems
Magnetic Particle Imaging (MPI) Systems
By Component
Devices / Instruments
Reagents and Contrast Agents
Software and Analytics
By Application
Oncology
Cardiology
Neurology and Central Nervous System (CNS) Diseases
Infectious and Immunological Diseases
Biodistribution and Pharmacokinetics Studies
By End-User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Small Animal Imaging (In-Vivo) Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
7.5. North America Small Animal Imaging (In-Vivo) Market Size Outlook by Type
7.6. North America Small Animal Imaging (In-Vivo) Market Size Outlook by Application
7.7. North America Small Animal Imaging (In-Vivo) Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Small Animal Imaging (In-Vivo) Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Small Animal Imaging (In-Vivo) Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Small Animal Imaging (In-Vivo) Companies
CHAPTER 8- EUROPE SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Small Animal Imaging (In-Vivo) Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
8.5. Europe Small Animal Imaging (In-Vivo) Market Size Outlook by Type
8.6. Europe Small Animal Imaging (In-Vivo) Market Size Outlook by Application
8.7. Europe Small Animal Imaging (In-Vivo) Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Small Animal Imaging (In-Vivo) Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Small Animal Imaging (In-Vivo) Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Small Animal Imaging (In-Vivo) Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Small Animal Imaging (In-Vivo) Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Small Animal Imaging (In-Vivo) Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Small Animal Imaging (In-Vivo) Companies
CHAPTER 9- ASIA PACIFIC SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Small Animal Imaging (In-Vivo) Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Small Animal Imaging (In-Vivo) Market Size Outlook by Type
9.6. Asia Pacific Small Animal Imaging (In-Vivo) Market Size Outlook by Application
9.7. Asia Pacific Small Animal Imaging (In-Vivo) Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Small Animal Imaging (In-Vivo) Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Small Animal Imaging (In-Vivo) Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Small Animal Imaging (In-Vivo) Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Small Animal Imaging (In-Vivo) Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Small Animal Imaging (In-Vivo) Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Small Animal Imaging (In-Vivo) Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Small Animal Imaging (In-Vivo) Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
10.5. South and Central America Small Animal Imaging (In-Vivo) Market Size Outlook by Type
10.6. South and Central America Small Animal Imaging (In-Vivo) Market Size Outlook by Application
10.7. South and Central America Small Animal Imaging (In-Vivo) Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Small Animal Imaging (In-Vivo) Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Small Animal Imaging (In-Vivo) Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Small Animal Imaging (In-Vivo) Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SMALL ANIMAL IMAGING (IN-VIVO) MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Small Animal Imaging (In-Vivo) Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Small Animal Imaging (In-Vivo) Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Small Animal Imaging (In-Vivo) Market Size Outlook by Type
11.6. Middle East and Africa Small Animal Imaging (In-Vivo) Market Size Outlook by Application
11.7. Middle East and Africa Small Animal Imaging (In-Vivo) Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Small Animal Imaging (In-Vivo) Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Small Animal Imaging (In-Vivo) Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Small Animal Imaging (In-Vivo) Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Small Animal Imaging (In-Vivo) Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Small Animal Imaging (In-Vivo) Industry
Bruker Corporation
PerkinElmer Inc.
Siemens Healthineers AG
FUJIFILM Holdings Corporation (VisualSonics)
Mediso Ltd.
LI-COR Biosciences
MR Solutions Ltd.
MILabs B.V. (Rigaku Corporation)
Aspect Imaging Ltd.
TriFoil Imaging Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
